Cosmos Health insider reports 9.97% stake

Cosmos Health Inc. disclosure shows Andreas Bovopoulos beneficially owns 3,733,412 shares of common stock, representing 9.974% of the class.

Rhea-AI Filing Summary

Cosmos Health Inc. disclosure shows Andreas Bovopoulos beneficially owns 3,733,412 shares of common stock, representing 9.974% of the class. The percentage is calculated against approximately 37,432,522 shares outstanding as of February 24, 2026.

The filing states Mr. Bovopoulos has sole voting power and sole dispositive power over the 3,733,412 shares. This entry appears as an amendment to a prior Schedule 13G/A and records beneficial ownership at the disclosed level.

Insights

Corporate Governance Expert

Large passive stake with sole control of voting and disposition reported.

The schedule shows 3,733,412 shares and 9.974% ownership, with sole voting and sole dispositive power. The filing documents a substantial minority position under applicable beneficial ownership thresholds.

Implications depend on the holder's intent; the filing itself does not state any planned corporate actions. Subsequent disclosures or filings may clarify whether this ownership leads to engagement or changes in governance.

Equity Markets Analyst

Stake size approaches the 10% mark cited by the filer, creating potential market attention.

The reported stake equals 3,733,412 shares versus an outstanding base of 37,432,522 shares as of February 24, 2026, yielding 9.974%. The position is disclosed via a Schedule 13G/A amendment.

Market effects depend on any future transactions; cash‑flow treatment and trading intentions are not stated in the excerpt. Future filings would show any purchases or sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake did Andreas Bovopoulos report in Cosmos Health (COSM)?

He reported beneficial ownership of 3,733,412 shares, equal to 9.974% of the class. The percentage is calculated from approximately 37,432,522 shares outstanding as of February 24, 2026.

Does Andreas Bovopoulos have voting control over his Cosmos Health shares?

Yes. The filing states he has sole voting power and sole dispositive power over 3,733,412 shares. The Schedule lists no shared voting or dispositive power for these shares.

What document reports this ownership and is it an amendment?

The position is reported on a Schedule 13G/A entry identified as Amendment No. 2. The filing updates previously reported beneficial ownership information for the holder.

How was the 9.974% ownership percentage calculated?

The percentage is based on approximately 37,432,522 shares outstanding as of February 24, 2026. Using that base, 3,733,412 shares represent 9.974% of the class.

Does the filing state any planned transactions or intentions by the holder?

No. The excerpt documents beneficial ownership and voting/dispositive power but does not state any planned purchases, sales, or intentions by Andreas Bovopoulos.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 05:17 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Cosmos Health Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03/09/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Bovopoulos Andreas

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,733,412.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,733,412.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,733,412.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Percentage based on approximately 37,432,522 shares of common stock outstanding as of February 24, 2026, based on publicly available information. Based on this number, the percentage of class represented is approximately 9.974%.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cosmos Health Inc.
(b)	Address of issuer's principal executive offices: 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, GREECE, 55438
Item 2.
(a)	Name of person filing: Andreas Bovopoulos
(b)	Address or principal business office or, if none, residence: 15413 Lone Hill Road Los Gatos, CA 95032
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 221413305
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,733,412
(b)	Percent of class: 9.974%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,733,412
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,733,412
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bovopoulos Andreas

Signature:	Andreas Bovopoulos
Name/Title:	Individual Investor
Date:	03/10/2026